These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 20832360)
1. Brk/PTK6 signaling in normal and cancer cell models. Ostrander JH; Daniel AR; Lange CA Curr Opin Pharmacol; 2010 Dec; 10(6):662-9. PubMed ID: 20832360 [TBL] [Abstract][Full Text] [Related]
2. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK. Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922 [TBL] [Abstract][Full Text] [Related]
3. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Castro NE; Lange CA Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression. Lukong KE; Larocque D; Tyner AL; Richard S J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349 [TBL] [Abstract][Full Text] [Related]
5. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration. Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872 [TBL] [Abstract][Full Text] [Related]
6. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest. Lukong KE; Huot ME; Richard S Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179 [TBL] [Abstract][Full Text] [Related]
7. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR. Li X; Lu Y; Liang K; Hsu JM; Albarracin C; Mills GB; Hung MC; Fan Z Oncogene; 2012 Oct; 31(40):4372-83. PubMed ID: 22231447 [TBL] [Abstract][Full Text] [Related]
8. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995 [TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Weaver AM; Silva CM Breast Cancer Res; 2007; 9(6):R79. PubMed ID: 17997837 [TBL] [Abstract][Full Text] [Related]
10. Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis. Regan Anderson TM; Ma S; Perez Kerkvliet C; Peng Y; Helle TM; Krutilina RI; Raj GV; Cidlowski JA; Ostrander JH; Schwertfeger KL; Seagroves TN; Lange CA Mol Cancer Res; 2018 Nov; 16(11):1761-1772. PubMed ID: 29991529 [TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells. Brauer PM; Zheng Y; Wang L; Tyner AL Cell Cycle; 2010 Oct; 9(20):4190-9. PubMed ID: 20953141 [TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition. Tsui T; Miller WT Biochemistry; 2015 May; 54(20):3173-82. PubMed ID: 25940761 [TBL] [Abstract][Full Text] [Related]
13. Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition. Ai M; Liang K; Lu Y; Qiu S; Fan Z Cancer Biol Ther; 2013 Mar; 14(3):237-45. PubMed ID: 23291984 [TBL] [Abstract][Full Text] [Related]
14. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration. Lukong KE; Richard S Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133 [TBL] [Abstract][Full Text] [Related]
15. Impact of protein tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer. Ludyga N; Anastasov N; Gonzalez-Vasconcellos I; Ram M; Höfler H; Aubele M Mol Biosyst; 2011 May; 7(5):1603-12. PubMed ID: 21380407 [TBL] [Abstract][Full Text] [Related]
16. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells. Ikeda O; Sekine Y; Mizushima A; Nakasuji M; Miyasaka Y; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T J Biol Chem; 2010 Dec; 285(49):38093-103. PubMed ID: 20929863 [TBL] [Abstract][Full Text] [Related]
17. Deregulation of the cell cycle by breast tumor kinase (Brk). Chan E; Nimnual AS Int J Cancer; 2010 Dec; 127(11):2723-31. PubMed ID: 20162673 [TBL] [Abstract][Full Text] [Related]
18. Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Ostrander JH; Daniel AR; Lofgren K; Kleer CG; Lange CA Cancer Res; 2007 May; 67(9):4199-209. PubMed ID: 17483331 [TBL] [Abstract][Full Text] [Related]
19. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors. Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721 [TBL] [Abstract][Full Text] [Related]
20. The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin. Brauer PM; Zheng Y; Evans MD; Dominguez-Brauer C; Peehl DM; Tyner AL PLoS One; 2011 Mar; 6(3):e14789. PubMed ID: 21479203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]